ESG in 10 Fidante

In this episode of ESG in 10, we delve into the crucial intersection of AI and responsible investing. With the exponential growth of AI-driven businesses, investors are grappling with how to gauge the responsible use of this technology. Alphinity Investment Management, in collaboration with CSIRO’s Data61 team, presents a groundbreaking framework aimed at guiding investors in assessing the ethical deployment of AI. Tune in as we explore key insights from their comprehensive research report, discuss engagement activities, and provide an overview of the investment framework, empowering investors to integrate responsible AI considerations into their investment strategies.Find out more about Alphinity's Responsible AI Framework for Investors 

By 2030, more than 60% of the world’s population will live and eat in Asia. With the growing demand for sustainable food production, there are many challenges and opportunities with the changing demographics and demand for food in the region. In this episode, Charlotte is joined by Tai Lin, Managing Partner at Proterra Asia, to dissect the complexities of this evolving landscape, exploring the shifting demographics and evolving dietary habits driving the surge in food demand across Asia.

Did you know? According to a Walk Free Report, one in every 130 females globally is living in modern slavery. Women and girls account for nearly three-quarters (71%) of all victims. This stark reality sheds light on the disproportionate impact of modern slavery on women and girls, highlighting the urgent need for action.
In this episode, we delve deep into this crucial topic with Melissa Stewart, founder of Stewardship Advisory and a member of the Alphinity Sustainable Fund Compliance Committee.
Tune is as we discuss the impact of gender inequality on modern slavery prevalence and explore how investors can play a pivotal role in addressing this issue.

In this episode of ESG in 10, Charlotte O'Meara is joined by Gillian Jago, Senior Trader at Ardea Investment Management, to explore the dominance of Europe in sovereign green bond issuance amid a global slowdown. They delve into the drivers behind Europe's success, compare the global approaches to green policies, and provide insights into the outlook for green bond issuance in the remaining weeks of 2023.You can read the full paper by Ardea Investment Management here-Why Europe is the region leading sovereign green bond issuance and what we expect for the last three months of the year - Ardea Investment Management

In this episode, Charlotte is joined by Chris Whitcombe, Head of Global ABS, and Michael Cistulli, Analyst, at Challenger Investment Management, as they delve into the challenges and advancements of integrating ESG considerations in Asset Backed Securities (ABS). Together, they explore the global landscape of ESG integration and take a closer look at the CIM approach for evaluating ESG risks within ABS transactions.

In this episode, Charlotte is joined by Moana Nottage from Alphinity Investment Management to discuss her research into Antimicrobial Resistance (AMR) and the importance of integrating AMR as a factor into the investment and stewardship process.  
When used correctly, antimicrobials play a key role in treating human and animal health. Antibiotics in particular have saved millions of lives since the 1940s and have contributed significantly to the life expectancy we see today. But microorganisms are becoming more resistant to contemporary medicine. Without responsible antimicrobial use, disease prevention and research into alternatives, the systemic risk posed by antimicrobial resistance (AMR) could be extremely disruptive. 
 
Learn More:
Antimicrobial Resistance: An emerging ESG consideration - AlphinityAntimicrobial resistance: Relevance to investors - AlphinityEU Action on Antimicrobial Resistance (europa.eu)